The endocannabinoid system as an emerging target of pharmacotherapy.

Author(s): Pacher P, Bátkai S, Kunos G

Laboratory of Physiological Studies, National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Room 2S-24, Bethesda, MD 20892-9413, USA.

Subject: General View the study

Abstract:

The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease. Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase. In the past decade, the endocannabinoid system has been implicated in a growing number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs...

Source: Pharmacological Reviews
Share Tweet

More medical studies related to General:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

www.fashioncarpet.com.ua

подробнее на jaamboo.com.ua

https://exstraeconom.kiev.ua/